Comparing Two Glaucoma Drainage Devices
Part of Eyes & vision clinical trials.
This trial compares two different tiny drainage devices (a gel stent and a microshunt) for lowering eye pressure in people with certain types of glaucoma that are not well controlled with medications. The goal is to see which device works better and is safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 40 years old.
- You have a specific type of glaucoma: primary open-angle, normal-tension, pigmentary, or pseudoexfoliative glaucoma.
- Your eye pressure is not controlled well with maximum eye drops or other medications.
- You have not had previous glaucoma surgery (like a shunt or laser) in the last 3 months, or other eye surgery on the white part of the eye.
- You are not currently using steroid eye drops or steroids by mouth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of glaucoma surgery to see which one works better for people with specific kinds of open-angle glaucoma whose eye pressure isn't controlled by eye drops or laser.
This study compares two surgical drainage devices used for glaucoma and looks at how they affect the clear front window of the eye (the cornea). It may help you understand which device is gentler on the cornea over time.
This trial compares two types of glaucoma drainage devices (Baerveldt and Paul) in people whose glaucoma is not well controlled with eye drops. It aims to find which device works better at lowering eye pressure and is safer.
This trial tests two small drainage devices (PreserFlo and XEN stents) for glaucoma, sometimes with an amniotic membrane. The goal is to see which approach is safer and more effective at lowering eye pressure.
This trial compares two glaucoma operations to see which works better at lowering eye pressure and keeping the eye stable. It’s for adults with open-angle glaucoma who are eligible for either surgery and can attend follow-up visits.
This trial tests a new gel stent (XEN63) to lower eye pressure in adults with glaucoma. It compares two ways of putting the stent in the eye, and may help people who have not had success with other treatments.
Hear when a new GLAUCOMA 1, OPEN ANGLE, D (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.